Private Institute Briefs

The Liposome Solution The benefits of many drugs, especially those used to combat cancer, are compromised by their toxicity. Now a Berkeley, Calif., researcher believes he has developed a technology that overcomes this problem, thus making possible more successful treatments of cancer and other diseases - and changing the way pharmaceutical companies will do science. Kenneth Matsumura, director of the Alin Foundation's Immunity Research Laboratory, believes he has found a method of using liposo

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Liposome Solution The benefits of many drugs, especially those used to combat cancer, are compromised by their toxicity. Now a Berkeley, Calif., researcher believes he has developed a technology that overcomes this problem, thus making possible more successful treatments of cancer and other diseases - and changing the way pharmaceutical companies will do science. Kenneth Matsumura, director of the Alin Foundation's Immunity Research Laboratory, believes he has found a method of using liposomes, tiny microspheres of lipid, to carry antidotes to nondiseased cells needing protection from the side effects of therapeutic drugs. In animal studies, Matsumura has been able to reduce or eliminate side effects caused by common cancer drugs, including methrotrexate, a breast cancer therapeutic that typically destroys bone marrow. According to Matsumura, this technology immediately opens up to drug researchers a range of useful drugs that have been discarded because of their toxicity. "We have on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies